Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50017225
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179206(3-trifluoromethyl-N-(6,7-dimethoxy-2,4-dihydroinde...)
Affinity DataIC50: 1nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 3nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179212(3-chloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 4.20nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179211(3-bromo-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]p...)
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179209((6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-y...)
Affinity DataIC50: 9nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179209((6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-y...)
Affinity DataIC50: 9nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179210((7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ph...)
Affinity DataIC50: 9nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179204(3-methoxy-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179204(3-methoxy-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179216(3-carbomethoxy-N-(6,7-dimethoxy-2,4-dihydroindeno[...)
Affinity DataIC50: 11nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179216(3-carbomethoxy-N-(6,7-dimethoxy-2,4-dihydroindeno[...)
Affinity DataIC50: 11nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179217(3-methyl-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 12nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179208(6,7-dimethoxy-3-phenyl-1,4-dihydroindeno[1,2-c]pyr...)
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179208(6,7-dimethoxy-3-phenyl-1,4-dihydroindeno[1,2-c]pyr...)
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179210((7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ph...)
Affinity DataIC50: 18nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 22nMAssay Description:Inhibitory activity against c-ABLMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179211(3-bromo-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]p...)
Affinity DataIC50: 32nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179206(3-trifluoromethyl-N-(6,7-dimethoxy-2,4-dihydroinde...)
Affinity DataIC50: 38nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor alpha(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 45nMAssay Description:Inhibitory activity against PDGFRalphaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179213((5-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ph...)
Affinity DataIC50: 54nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase Lck(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 100nMAssay Description:Inhibitory activity against LCKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179221(2-chloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 110nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179214(3-cyano-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]p...)
Affinity DataIC50: 137nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProto-oncogene tyrosine-protein kinase Src(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 185nMAssay Description:Inhibitory activity against c-SRCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179217(3-methyl-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 188nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179215((6-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ph...)
Affinity DataIC50: 217nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179212(3-chloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 268nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179220(3,5-dichloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,...)
Affinity DataIC50: 310nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179205((2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine ...)
Affinity DataIC50: 317nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase Fyn(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 378nMAssay Description:Inhibitory activity against FYNMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179222(3,4-dichloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,...)
Affinity DataIC50: 410nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179213((5-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)ph...)
Affinity DataIC50: 487nMAssay Description:Antiproliferative activity against PDGF-BB stimulated HCASMCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179223(4-chloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]...)
Affinity DataIC50: 659nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179219(3-carboxy-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c...)
Affinity DataIC50: 800nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 1/2/3(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibitory activity against VEGFRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179218(2,4-dichloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,...)
Affinity DataIC50: 5.42E+3nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179224(2,5-dichloro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,...)
Affinity DataIC50: 6.22E+3nMAssay Description:Inhibitory activity against PDGFRbeta kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCasein kinase I isoform alpha/delta/epsilon/gamma-1/gamma-2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibitory activity against Casein Kinase 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity against CDK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity against HER2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibitory activity against GSK3More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 4.58E+4nMAssay Description:Inhibitory activity against bFGFR1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 7(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 5.67E+4nMAssay Description:Inhibitory activity against CDK7More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 4(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against CDK4More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against MAPKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCyclin-dependent kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against CDK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetFocal adhesion kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against FAKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against EGFRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetcAMP-dependent protein kinase catalytic subunit alpha/beta/gamma(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50179207(JNJ-10198409 | 3-fluoro-N-(6,7-dimethoxy-2,4-dihyd...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against PKAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: